510(k) for Boston Scientific's advanced mapping catheter:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared Boston Scientific's Constellation mapping catheter for the diagnosis and treatment of complex right atrial tachycardias through direct contact with the heart tissue. The device allows the atrium to be mapped in a few heart beats and its multiple electrodes provide data which help doctors decide where to perform catheter ablation, said the company.